Navigation Links
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in AMAG Pharmaceuticals, Inc. of Class Action Lawsuit Investigation - AMAG
Date:5/28/2013

NEW YORK, May 28, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of AMAG Pharmaceuticals, Inc. ("AMAG" or the "Company") (NASDAQ: AMAG) (CUSIP: 00163U106 ) who purchased AMAG common stock between May 10, 2012 and May 21, 2013 (the "Class Period"). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.

The investigation concerns whether AMAG and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On May 22, 2013, the Company announced in regulatory filing that it has been made aware by Takeda Pharmaceutical Company Limited, the exclusive product distributor of ferumoxytol in Switzerland, that it is recalling one specific batch of Rienso, ferumoxytol, from the Swiss market. This decision is based on a cluster of four post-marketing adverse event reports in Switzerland concerning hypersensitivity reactions of varying severity following the administration of Rienso from the recalled batch, and at least one fatality has occurred as a result of the use of the drug in Switzerland.  On this news announcement, shares of AMAG fell $2.68 or 10.68% to close at $22.40 on May 22, 2013.

The Pomerantz Firm, with offices in New York, Chicago, San Diego, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz , known as the dean of the class action bar, the Pom
'/>"/>

SOURCE Pomerantz Grossman Hufford Dahlstrom & Gross LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. OncoSec Medical Issues Letter to Shareholders
2. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
3. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
4. Ampios CEO and CSO Send Message to Shareholders
5. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
6. Sinovac Schedules 2012 Annual Meeting of Shareholders
7. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
8. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
9. Carl Icahn Issues Open Letter to Shareholders of Forest Laboratories
10. AMRI Renews Shareholder Rights Plan
11. AspenBio Pharma to Provide Shareholders with Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... N.C. , May 1, 2015  An ... that can provide non-binding but informed guidance to ... the return on investment, it is important for ... invest optimal resources. Research and ... study to assist pharmaceutical and medical device executives ...
(Date:5/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vzcw2v/americas_clinical ) has announced ... by Product, by End-Users - Forecast to 2019" report ... market is estimated to grow at a CAGR of 5.2% ... Canada , Mexico , ... covered in this report. The Americas is the ...
(Date:5/1/2015)... 2015 Following yesterday,s release of Center for Medicaid ... five things you need to know: ... unique among government programs. ... than other parts of Medicare and other government programs because ... to offer prescription drug benefits to enrollees. , Competition ...
Breaking Medicine Technology:New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 25 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3
... 1, 2012 The FDA and representatives from the ... on proposed recommendations for the third reauthorization of a ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The recommendations would authorize the ... five years, plus adjustments for inflation. Details of the ...
... Corporation (NYSE: BSX ) announces first ... PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent ... the new device was performed by Professor Antonio ... at Columbus Hospital and San Raffaele Hospital in ...
Cached Medicine Technology:FDA and Industry Reach Agreement in Principle on Medical Device User Fees 2FDA and Industry Reach Agreement in Principle on Medical Device User Fees 3Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe 2Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe 3Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe 4
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch as ... and coolest technology products available to consumers. Scott Steinberg, a ... and shared with viewers how to protect their private information. ... on computers and even more so online. It helps everyone ... over the world. In terms of work, the internet makes ...
(Date:5/3/2015)... May 03, 2015 SpineFrontier, a Less ... the FDA to produce and market their new sacroiliac ... be used in outpatient settings and is compatible with ... posterior approach has been extensively researched and refined by ... to use this approach in conjunction with a sacroiliac ...
(Date:5/2/2015)... As one of only 30 Illinois companies to be ... and Recognition Program (SHARP) certification, Essentra Specialty Tapes ... Department of Labor to host this special event. ... the Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation ... or exceed all of the necessary regulations and standards, ...
(Date:5/2/2015)... “ ActOn ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... organizations to make a difference. , In this material world, ... that aren’t about money, which is why those things should ...
(Date:5/2/2015)... We are pleased to announce the Sun ... one of the Top Workplaces of 2015. , The ... field for their ethics and standards of excellence. The ... their educational efforts. The Delray Recovery Center prides itself ... purpose – to help individuals heal from the disease ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2
... factors for spontaneous or unexpected preterm birth any birth ... without a known cause is already having had one. ... this scenario in their second pregnancy, focusing on weight gain ... new study reported at the Society for Maternal-Fetal Medicine,s annual ...
... HealthDay Reporter , THURSDAY, Feb. 9 (HealthDay News) -- A ... had chemotherapy while pregnant aren,t at higher risk for a ... be safe for the fetus in most instances. There,s ... were more likely to be born prematurely, potentially putting them ...
... Annual Meeting of the American Academy of Orthopaedic Surgeons ... living with a total knee replacement (TKR), as the ... the past decade, with the sharpest rise among younger ... TKR., Investigators used a computer model; U.S. Census data; ...
... (February 10, 2012) In a study to be ... meeting, The Pregnancy Meeting , in Dallas, Texas, researchers ... can be used to diagnose fetal aneuploidies, including Down ... Because of the importance of the clinical data, the ...
... obstructive sleep apnea had substantial improvements in attention, anxiety ... pressure (PAP)a nighttime therapy in which a machine delivers ... nose. "The benefits occurred even when children ... Carole L. Marcus, M.D., a sleep specialist and director ...
... , THURSDAY, Feb. 9 (HealthDay News) -- Small, premature ... higher risk for serious breathing problems than those delivered ... syndrome, which mostly affects premature newborns and can lead ... more common in the babies born by cesarean, or ...
Cached Medicine News:Health News:To avoid early labor and delivery, weight and diet changes not the answer 2Health News:Chemo During Pregnancy Doesn't Seem to Harm Baby 2Health News:Chemo During Pregnancy Doesn't Seem to Harm Baby 3Health News:4.5 million Americans living with total knee replacement 2Health News:Study finds massively parallel sequencing can detect fetal aneuploidies, including Down syndrome 2Health News:Sleep breathing machine shows clear benefits in children with sleep apnea 2Health News: C-Sections Might Put Preemies at Risk for Breathing Problems 2Health News: C-Sections Might Put Preemies at Risk for Breathing Problems 3
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
Medicine Products: